skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Update on duloxetine for the management of stress urinary incontinence

Review

(3487) Views  (765) Full article downloads

Authors: Maya Basu, Jonathan RA Duckett

Published Date November 2008 Volume 2009:4 Pages 25 - 30
DOI: http://dx.doi.org/10.2147/CIA.S4062

Maya Basu, Jonathan RA Duckett

Department of Obstetrics and Gynaecology, Medway Maritime Hospital, Gillingham, Kent, UK

Abstract: Duloxetine is a relatively balanced serotonin and noradrenaline reuptake inhibitor (SNRI), which is the first drug with widely proven efficacy to have been licensed for the medical treatment of women with stress urinary incontinence (SUI). Despite favorable results from randomized controlled trials, surgical management continues to be the mainstay of treatment for SUI. In this review we explore the pharmacology of duloxetine in the nervous system and lower urinary tract, and the evidence for its use in the management of women with urinary incontinence.

Keywords: duloxetine, stress urinary incontinence, overactive bladder